Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2984332rdf:typepubmed:Citationlld:pubmed
pubmed-article:2984332lifeskim:mentionsumls-concept:C0026769lld:lifeskim
pubmed-article:2984332lifeskim:mentionsumls-concept:C0025815lld:lifeskim
pubmed-article:2984332lifeskim:mentionsumls-concept:C0035020lld:lifeskim
pubmed-article:2984332lifeskim:mentionsumls-concept:C0348016lld:lifeskim
pubmed-article:2984332pubmed:issue2lld:pubmed
pubmed-article:2984332pubmed:dateCreated1985-4-26lld:pubmed
pubmed-article:2984332pubmed:abstractTextA randomised comparison is made between methylprednisolone, 1 g intravenously daily for 7 days, and a standard ACTH regime for the treatment of multiple sclerosis in acute relapse. It is found that methylprednisolone produces a more rapid clinical improvement than ACTH but confers no longer term benefit when the two treatments are compared at 3 months. It is proposed that intravenous methylprednisolone does have a role to play in the management of a patient with an acute relapse of multiple sclerosis.lld:pubmed
pubmed-article:2984332pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2984332pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2984332pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2984332pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2984332pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2984332pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2984332pubmed:languageenglld:pubmed
pubmed-article:2984332pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2984332pubmed:citationSubsetIMlld:pubmed
pubmed-article:2984332pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2984332pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2984332pubmed:statusMEDLINElld:pubmed
pubmed-article:2984332pubmed:monthFeblld:pubmed
pubmed-article:2984332pubmed:issn0022-3050lld:pubmed
pubmed-article:2984332pubmed:authorpubmed-author:TilleyP JPJlld:pubmed
pubmed-article:2984332pubmed:authorpubmed-author:SaundersMMlld:pubmed
pubmed-article:2984332pubmed:authorpubmed-author:BatemanD EDElld:pubmed
pubmed-article:2984332pubmed:authorpubmed-author:NewmanP KPKlld:pubmed
pubmed-article:2984332pubmed:authorpubmed-author:ClelandP GPGlld:pubmed
pubmed-article:2984332pubmed:authorpubmed-author:WallsT JTJlld:pubmed
pubmed-article:2984332pubmed:authorpubmed-author:BarnesM PMPlld:pubmed
pubmed-article:2984332pubmed:authorpubmed-author:DickD JDJlld:pubmed
pubmed-article:2984332pubmed:issnTypePrintlld:pubmed
pubmed-article:2984332pubmed:volume48lld:pubmed
pubmed-article:2984332pubmed:ownerNLMlld:pubmed
pubmed-article:2984332pubmed:authorsCompleteYlld:pubmed
pubmed-article:2984332pubmed:pagination157-9lld:pubmed
pubmed-article:2984332pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:2984332pubmed:meshHeadingpubmed-meshheading:2984332-...lld:pubmed
pubmed-article:2984332pubmed:meshHeadingpubmed-meshheading:2984332-...lld:pubmed
pubmed-article:2984332pubmed:meshHeadingpubmed-meshheading:2984332-...lld:pubmed
pubmed-article:2984332pubmed:meshHeadingpubmed-meshheading:2984332-...lld:pubmed
pubmed-article:2984332pubmed:meshHeadingpubmed-meshheading:2984332-...lld:pubmed
pubmed-article:2984332pubmed:meshHeadingpubmed-meshheading:2984332-...lld:pubmed
pubmed-article:2984332pubmed:meshHeadingpubmed-meshheading:2984332-...lld:pubmed
pubmed-article:2984332pubmed:meshHeadingpubmed-meshheading:2984332-...lld:pubmed
pubmed-article:2984332pubmed:meshHeadingpubmed-meshheading:2984332-...lld:pubmed
pubmed-article:2984332pubmed:meshHeadingpubmed-meshheading:2984332-...lld:pubmed
pubmed-article:2984332pubmed:meshHeadingpubmed-meshheading:2984332-...lld:pubmed
pubmed-article:2984332pubmed:meshHeadingpubmed-meshheading:2984332-...lld:pubmed
pubmed-article:2984332pubmed:meshHeadingpubmed-meshheading:2984332-...lld:pubmed
pubmed-article:2984332pubmed:meshHeadingpubmed-meshheading:2984332-...lld:pubmed
pubmed-article:2984332pubmed:year1985lld:pubmed
pubmed-article:2984332pubmed:articleTitleIntravenous methylprednisolone for multiple sclerosis in relapse.lld:pubmed
pubmed-article:2984332pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2984332pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:2984332pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2984332lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2984332lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2984332lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2984332lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2984332lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2984332lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2984332lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2984332lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2984332lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2984332lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2984332lld:pubmed